Cequent Pharmaceuticals
Early Stage Biopharmaceutical
An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human diseases – from inflammatory diseases to cancer – based on the company’s proprietary technology,...Founded in 2006
Homepage: http://www.cequentpharma.com/
Total money raised: $12.4M
02139
One Kendall Square
Building 700, First Floor
Cambridge
USA MA
Building 700, First Floor
Cambridge
USA MA
Phone: 617.995.7940
Updated on Feb 13, 2011
Cequent Pharmaceuticals at CrunchBase
PastCequent Pharmaceuticals at CrunchBase
Peter Parker President, CEO
Lisa Velardo CFO
Susie Truong Harborth VP Operations
Ted Hibben Chief Business Officer
October, 2009
Cequent Pharmaceuticals raised $3.4M in a Series B round
Xconomy Boston 
xconomy.com
June, 2007
Cequent Pharmaceuticals raised $9M in a Series A round from Novartis Option Fund, Ampersand Capital Partners, Nexus Medical Partners, and Pappas Ventures
Cequent Pharmaceuticals 
cequentpharma.com
2006
Cequent Pharmaceuticals was founded in 2006